Cambridge Cog Share News (COG)

Cambridge Cognition products to be used in Alzheimer's study

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday announced a collaboration for its NeuroVocalix and CANTAB products.

TRADING UPDATES: Virgin Wines loses fizz; M&C revenue improves

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Director dealings: Cambridge Cognition execs invest after solid update

(Sharecast News) - Cambridge Cognition was among a relatively thin list of director deals on Friday afternoon, after two of its executives made share purchases.

Cambridge Cognition half-year revenue jumps 31%, order book grows

(Alliance News) - Cambridge Cognition Holdings PLC on Thursday said revenue grew strongly in the first half of 2022.

TRADING UPDATES: Altona Rare Earths positive on Monte Maumbe project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

IN BRIEF: Cambridge Cognition appoints new chief financial officer

Cambridge Cognition Holdings PLC- Cambridge-based neuroscience technology company - Appoints Stephen Symonds as chief financial officer with effect "in due course".

UK earnings, trading statements calendar - next 7 days

Cambridge Cognition wins phase 3 contract worth over £1m

(Sharecast News) - Brain health technology developer Cambridge Cognition has won a contract worth just over £1m with an unnamed "top 10" pharmaceutical company, it announced on Monday, to provide digital cognitive assessments for a pivotal phase 3 autoimmune disease trial.

IN BRIEF: Cambridge Cognition wins GBP1 million contract

Cambridge Cognition Holdings PLC- Cambridge, neuroscience technology company - Wins contract with an unnamed "top 10" pharmaceutical company. The contract worth over GBP1 million will see Cambridge Cognition provide digital cognitive assessments for a phase III autoimmune disease trial. Revenue from the contract is expected over the next three years.

AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Sunday share tips: Cambridge Cognition Holdings, FRP

(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.

Cambridge Cognition awarded contracts worth £2.1m

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and third-party hardware for two clinical trials in neurodegenerative disease.

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Cambridge Cognition jumps on GBP2.1 million clinical trial contract